Rockwell Medical 

€3.32
47
+€0.2+6.27% Thursday 14:34

Statistik

Harga Tertinggi Hari
3.32
Harga Terendah Hari
3.2
52M Tertinggi
-
52M Terendah
-
Volum
599
Volum Purata
-
Kapasiti Pasaran
97.63M
Nisbah P/E
-
Pendapatan Dividen
-
Dividen
-

Akan Datang

Pendapatan

11NovDijangka
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Seterusnya
-0.18
-0.11
-0.05
0.02
EPS yang dijangka
0.01
EPS sebenar
N/A

Orang Lain Juga Mengikuti

Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti RWMA.F. Ini bukan cadangan pelaburan.

Peserta

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.

Mengenai

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Show more...
CEO
Dr. Mark Strobeck Ph.D.
Pekerja
237
Negara
US
ISIN
US7743743004
WKN
000A3DL8F

Penyenaraian